Form 8.3

Summary by AI BETAClose X

Qube Research disclosed a cash-settled derivative position referencing 7,994,777 Advanced Medical Solutions 5p ordinary shares, representing 3.61% of the share capital, with zero direct shareholdings and zero short positions; the position was held on 03-11-2026 and disclosed on 04-11-2026. Disclosed dealings show equity-swap increases of 2,822 units at 282.50p and 21,797 units at 283.00p, and the filing states no stock-settled derivatives, no subscription rights and no indemnities or other dealing arrangements.

Disclaimer*

UK 100

Latest directors dealings